Authors
Latest:
Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic DermatitisRecent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.
Latest:
Do You Have the Right Financial Adviser?Experts detail 5 tips to ask a financial advisor so they can best serve your interests.
Latest:
Pipeline Updates on the Horizon From Arcutis BiotherapeuticsPatrick Burnett, MD, PhD, shares key updates expected in 2025 for therapeutics treating atopic dermatitis, alopecia areata, and more.
Latest:
Del Rosso Highlights Next-Gen TreatmentsAt the Fall Clinical PA/NP 2025 meeting, James Del Rosso, DO, spoke about recently approved therapies like JAKis for alopecia, biologics for AD, and tirbanibulin for AKs.
Latest:
Exploring the Diagnostics of Urticaria at ACAAISession at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.
Latest:
Kim Papp, MD, PhD, FRCPC: Exploring the Potential of ESK-001 in Plaque PsoriasisPapp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.
Latest:
Why Treating Scalp Psoriasis With Topicals Remains a ChallengePanelists discuss how treating scalp psoriasis remains challenging due to poor compatibility of traditional topicals with hair and scalp characteristics, emphasizing the need for cosmetically acceptable, well-tolerated formulations that improve adherence and reduce premature escalation to systemic therapy.
Latest:
OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.
Latest:
Potential Role of AI in HS DiagnosisPanelists discuss how the role of AI in Hidradenitis Suppurativa and the potential for complex multi-input factors.
Latest:
Does diet really play a role in acne?For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.
Latest:
An Overview of ArgyriaArgyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.
Latest:
Managing aBCC and aCSCC With Cemiplimab: Tips From Matthew Reynolds, PA-CReynolds discussed what attendees need to know about using cemiplimab to target their difficult skin cancer patients at the Fall Clinical Dermatology Conference for PAs and NPs.
Latest:
Clinical Challenges in Treating Atopic DermatitisPanelists discuss how managing atopic dermatitis presents complex clinical challenges, including treatment resistance, medication adherence, identifying triggers, and tailoring therapies to individual patient needs and disease severity.
Latest:
Melinda Gooderham, MD, MSc, FRCPC: Reaffirming Delgocitinib Safety With Minimal Absorption, Maximum ConfidenceGooderham continues a discussion on new data reinforcing the safety of topical delgocitinib, with minimal systemic absorption even under maximal use conditions.
Latest:
Why Atopic Dermatitis Treatment is Not “One Size Fits All,” According to Jiyeon OhJiyeon Oh’s research confirms that a personalized approach is needed to treat all complexities associated with AD.
Latest:
“Is AI Coming for My Job?”: Familiarizing Clinicians with AI Tools and Their Role in DermatologyIn a session at Elevate-Derm West, Cheever presented on the utilization of AI within dermatology to optimize patient communication and diversify research.
Latest:
Telehealth in 2023: What Physicians Need to KnowAnswers to some common questions about providing telehealth services in 2023.
Latest:
Final Thoughts on Tapinarof in AD Clinical TrialsRaj Chovatiya, MD, PhD, and Adelaide A. Hebert, MD, FAAD, review the study results for the ADORING 1 and ADORING 2 trials, as well as share closing thoughts on the use of tapinarof in management of AD.
Latest:
Nutraceuticals: A Boost for Skin HealthProper nutrition and nutraceuticals can help to manage skin conditions such as acne, eczema, and psoriasis.
Latest:
Exploring Advancements in Palmoplantar Pustulosis, Psoriasis Comorbidities, and PhototherapyJoel Gelfand, MD, discusses insights on complex psoriasis cases, comorbidity management, and the evolving role of phototherapy at Fall Clinical 2024.
Latest:
Key Insights From the SPD Pre-AAD Meeting: Advances, Challenges, and the Future of Pediatric DermatologyMercedes E. Gonzalez, MD, reflects on the SPD meeting as well as challenges and advances in pediatric dermatology.
Latest:
How to Avoid Complications With Radiofrequency and Ultrasound-Based TechnologiesAt AAD 2025, Karan Lal, DO, MS, FAAD, presented clinical insights on insulated microneedling tips, grounding pad issues in monopolar radiofrequency, and more.
Latest:
OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.
Latest:
Expanding Innovation and Education in Medical AestheticsBob Rhatigan, CEO of Merz Aesthetics, discusses the organization’s commitment to advancing the aesthetics industry through strategic partnerships, specialized training, and a growing portfolio of injectables and devices.
Latest:
Expert Perspectives on BOLT clinical trial dataJohn Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
